The Drug Tariff Preface published monthly lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 February 2023. Key g Special container – This product is a special container and should be dispensed in its complete original pack size. n Item [...]
The post Drug Tariff Watch – February 2023 appeared first on PSNC Website.
Class 3 Medicines recall: Lacidipine 4 mg Film-Coated Tablets (Dr Reddy’s Laboratories (UK) Ltd) Drug alert number: EL (23)A/03 Date issued: 19 January 2023 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 3 medicines recall for: Lacidipine 4 mg Film-Coated Tablets (Dr Reddy’s Laboratories (UK) Ltd), PL 08553/0503 Brief description of [...]
The post Class 3 Medicines Recall: Lacidipine 4 mg Film-Coated Tablets (Dr Reddy’s) appeared first on PSNC Website.
The Drug Tariff Preface published monthly lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 January 2023. Key g Special container – This product is a special container and should be dispensed in its complete original pack size. n Item [...]
The post Drug Tariff Watch – January 2023 appeared first on PSNC Website.
In response to significant ongoing disruption affecting supply of Phenoxymethylpenicillin oral solution, the Department of Health and Social Care (DHSC) has issued three new Serious Shortage Protocols (SSPs). The SSPs, introduced with immediate effect, allow community pharmacists to consider different options to enable continued supply of Phenoxymethylpenicillin to mitigate the ongoing supply disruptions affecting this [...]
The post Three SSPs issued for Phenoxymethylpenicillin (Pen V) oral solution appeared first on PSNC Website.
Update (30/01/2023) – Following representations from PSNC, the Department of Health of Social Care (DHSC) has re-determined the special container status of all Co-beneldopa capsules and tablets. In December 2022, PSNC advised that the special container rules apply to all branded or generically written prescriptions for Madopar® dispensed from December 2022 onwards (except for generically prescribed Co-beneldopa 12.5mg/50mg [...]
The post Co-beneldopa (including Madopar®) preparations re-classified as special containers appeared first on PSNC Website.
Recent Comments